184 related articles for article (PubMed ID: 16048249)
1. Effects of inhibition of the polyol pathway during chronic peritoneal exposure to a dialysis solution.
van Westrhenen R; Aten J; Aberra M; Dragt CA; Deira G; Krediet RT
Perit Dial Int; 2005 Feb; 25 Suppl 3():S18-21. PubMed ID: 16048249
[TBL] [Abstract][Full Text] [Related]
2. Role of the renin-angiotensin system in the pathogenesis of peritoneal fibrosis.
Nakamoto H; Imai H; Fukushima R; Ishida Y; Yamanouchi Y; Suzuki H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S83-7. PubMed ID: 18552271
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic administration in an animal model of chronic peritoneal dialysate exposure.
Mortier S; De Vriese AS; Leyssens A; Vanacker NJ; Faict D; Cornelissen M; De Ridder L; Lameire NH
Perit Dial Int; 2003; 23(4):331-8. PubMed ID: 12968840
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat.
Zweers MM; Splint LJ; Krediet RT; Struijk DG
Nephrol Dial Transplant; 2001 Mar; 16(3):651-4. PubMed ID: 11239059
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A induces peritoneal fibrosis and angiogenesis during chronic peritoneal exposure to a glucose-based, lactate-buffered dialysis solution in the rat.
van Westrhenen R; Aten J; Hajji N; de Boer OJ; Kunne C; de Waart DR; Krediet RT
Blood Purif; 2007; 25(5-6):466-72. PubMed ID: 18087149
[TBL] [Abstract][Full Text] [Related]
7. Catheter patency and peritoneal morphology and function in a rat model of citrate-buffered peritoneal dialysis.
Cavallini N; Braide M
Perit Dial Int; 2010; 30(6):602-10. PubMed ID: 20421429
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
[TBL] [Abstract][Full Text] [Related]
9. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
Zareie M; van Lambalgen AA; ter Wee PM; Hekking LH; Keuning ED; Schadee-Eestermans IL; Faict D; Degréve B; Tangelder GJ; Beelen RH; van den Born J
Perit Dial Int; 2005; 25(1):58-67. PubMed ID: 15770927
[TBL] [Abstract][Full Text] [Related]
10. A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution.
van Westrhenen R; Zweers MM; Kunne C; de Waart DR; van der Wal AC; Krediet RT
Perit Dial Int; 2008; 28(5):487-96. PubMed ID: 18708542
[TBL] [Abstract][Full Text] [Related]
11. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
12. The effects of a dialysis solution with a combination of glycerol/amino acids/dextrose on the peritoneal membrane in chronic renal failure.
de Graaff M; Zegwaard AH; Zweers MM; Vlijm A; de Waart DR; Vandemaele F; Struijk DG; Krediet RT
Perit Dial Int; 2010; 30(2):192-200. PubMed ID: 20124192
[TBL] [Abstract][Full Text] [Related]
13. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.
Zareie M; Hekking LH; Welten AG; Driesprong BA; Schadee-Eestermans IL; Faict D; Leyssens A; Schalkwijk CG; Beelen RH; ter Wee PM; van den Born J
Nephrol Dial Transplant; 2003 Dec; 18(12):2629-37. PubMed ID: 14605288
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three chronic dialysis models.
Peng WX; Guo QY; Liu SM; Liu CZ; Lindholm B; Wang T
Adv Perit Dial; 2000; 16():51-4. PubMed ID: 11045261
[TBL] [Abstract][Full Text] [Related]
15. The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure.
De Vriese AS; Mortier S; Cornelissen M; Palmans E; Vanacker NJ; Leyssens A; Faict D; De Ridder L; Lameire NH
Perit Dial Int; 2002; 22(5):566-72. PubMed ID: 12455567
[TBL] [Abstract][Full Text] [Related]
16. The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions.
Yao Q; Pawlaczyk K; Ayala ER; Styszynski A; Breborowicz A; Heimburger O; Qian JQ; Stenvinkel P; Lindholm B; Axelsson J
Nephron Exp Nephrol; 2008; 109(2):e71-8. PubMed ID: 18600031
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
[TBL] [Abstract][Full Text] [Related]
18. New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum.
Vlahu CA; Aten J; de Graaff M; van Veen H; Everts V; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2016 11-12; 36(6):614-622. PubMed ID: 27147290
[TBL] [Abstract][Full Text] [Related]
19. Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations.
Vrtovsnik F; Coester AM; Lopes-Barreto D; de Waart DR; Van der Wal AC; Struijk DG; Krediet RT; Zweers MM
Perit Dial Int; 2010; 30(5):558-69. PubMed ID: 20421431
[TBL] [Abstract][Full Text] [Related]
20. Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis?
Bozkurt D; Hur E; Ulkuden B; Sezak M; Nar H; Purclutepe O; Sen S; Duman S
Perit Dial Int; 2009 Feb; 29 Suppl 2():S202-5. PubMed ID: 19270218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
